BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 11, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 21, 2015
View Archived Issues
An attenuated, gD-deleted vaccine provides 100% protection against herpes simplex virus
Read More
Dose-escalation to proceed in phase I/II trial of Vivolux's iron chelator for cancer
Read More
Anika Therapeutics completes enrollment in repeat-injection study of Cingal
Read More
Combined use of cfDNA and CareDx's AlloMap to identify rejection in heart transplant recipients
Read More
Takeda initiates collaboration on identification and analysis of RNA-binding proteins
Read More
Panther licenses rights to TDZD-8 from University of Rochester
Read More
BNC-210 enters phase II evaluation for anxiety
Read More
Expedited development of lonafarnib with ritonavir for hepatitis D virus infection
Read More
Lilly reports phase III trial success with ixekizumab
Read More
CiRA and Takeda to collaborate on drug discovery using iPS cells
Read More
Mallinckrodt seals the deal with Ikaria
Read More
Brain cancer collaboration between Novogen and the Feinstein Institute announced
Read More
Ampio reports results from phase III trial STRIDE of Ampion in OA
Read More
SAGE Therapeutics initiates phase III expanded access study of SAGE-547 in SRSE
Read More
Sumitomo Dainippon Pharma reports mGlu5 receptor modulators
Read More
Polish scientists develop mGlu4 PAMs
Read More
PPARalpha antagonists hold promise as a complement to chemotherapy for pancreatic cancer
Read More
Paclitaxel trevatide named orphan drug in the U.S.
Read More
ZV-0201, an ADC for the treatment of HER2-positive cancers
Read More
University of California, Oakland presents integrin alphavbeta1 antagonists for fibrosis
Read More
Potent ADAM 17 antibody inhibits tumor growth
Read More
Vertex develops inhibitors of PAR2 signaling pathway
Read More
MBX-8025 receives FDA orphan status for Frederickson Type I or V hyperlipoproteinemia
Read More
Tamoxifen found to inhibit the effects of amphetamine
Read More
